Malignant breast tumors typically exhibit high levels of cyclooxygenase-2 (COX-2), and prostaglandin E2 (PGE2), the primary COX-2 product in cancer, contributes to the high metastatic capacity of breast tumors 140. This evidence concerns the gene PTGS2 and cancer.